Infusiegerelateerde reactie
Geneesmiddelen waarbij Infusiegerelateerde reactie kan optreden
| Geneesmiddel | Werkzame stof | Frequentie |
|---|---|---|
| amivantamab | amivantamab | Vaak |
| atezolizumab | atezolizumab | Vaak |
| avelumab | avelumab | Vaak |
| axicabtagen ciloleucel | axicabtagen ciloleucel | Vaak |
| belatacept | belatacept | Soms |
| brentuximab vedotin | brentuximab vedotin | Vaak |
| cemiplimab | cemiplimab | Vaak |
| daratumumab | daratumumab | Vaak |
| donanemab | donanemab | Vaak |
| dostarlimab | dostarlimab | Vaak |
| doxorubicine in gepegyleerde liposomen | doxorubicine in gepegyleerde liposomen | Vaak |
| durvalumab | durvalumab | Vaak |
| eculizumab | eculizumab | Vaak |
| enfortumab vedotin | enfortumab vedotin | Vaak |
| ipilimumab | ipilimumab | Soms |
| irinotecan in gepegyleerde liposomen | irinotecan in gepegyleerde liposomen | Vaak |
| isatuximab | isatuximab | Vaak |
| lisocabtagen maraleucel | lisocabtagen maraleucel | Vaak |
| mogamulizumab | mogamulizumab | Vaak |
| nivolumab | nivolumab | Vaak |
| obinutuzumab | obinutuzumab | Vaak |
| panitumumab | panitumumab | Soms |
| polatuzumab vedotin | polatuzumab vedotin | Vaak |
| ravulizumab | ravulizumab | Vaak |
| rurioctocog alfa pegol | rurioctocog alfa pegol | Soms |
| sacituzumab govitecan | sacituzumab govitecan | Soms |
| serplulimab | serplulimab | Vaak |
| tafasitamab | tafasitamab | Vaak |
| tisagenlecleucel | tisagenlecleucel | Vaak |
| trastuzumab-deruxtecan | trastuzumab-deruxtecan | Vaak |
| velaglucerase alfa | velaglucerase alfa | Vaak |
| velmanase alfa | velmanase alfa | Vaak |
| zolbetuximab | zolbetuximab | Vaak |